ClinicalTrials.Veeva

Menu

A Twelve Week Study of Supervised Mouth Rinse and Flossing

Johnson & Johnson (J&J) logo

Johnson & Johnson (J&J)

Status and phase

Completed
Phase 4

Conditions

Healthy

Treatments

Other: Alcohol-containing Essential Oil (AEO) Mouth Rinse (Listerine Cool Mint, marketed)
Other: 5% Hydroalcohol Mouth Rinse
Other: American Dental Association (ADA) Referenced Toothbrush
Other: Colgate Cavity Protection Toothpaste
Other: REACH Dental Floss

Study type

Interventional

Funder types

Industry

Identifiers

NCT04696536
CCSORC000708 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of twice daily alcohol containing essential oil mouth rinse and brushing versus dental flossing and brushing under once daily supervision for the prevention and reduction of plaque and gingivitis.

Enrollment

149 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Able to comprehend and follow the requirements and restrictions of the study (including willingness to use the assigned study products according to instructions, availability on scheduled visit dates and likeliness of completing the clinical study) based upon research site personnel's assessment
  • Able to attend once daily session during weekdays for flossing and rinsing occurring on site
  • Evidence of a personally signed and dated informed consent document indicating the subject (or legally acceptable representative) has been informed of all pertinent aspects of the trial
  • Able to read and understand the local language (participants capable of reading the documents)
  • Adequate oral hygiene (that is brush teeth daily and exhibit no signs or oral neglect)
  • A minimum of 20 natural teeth with scorable facial and lingual surfaces. Teeth that are grossly carious, extensively restored, orthodontically banded, abutments, exhibiting severe generalized cervical and/or enamel abrasion, or third molars will not be included in the tooth count
  • A minimum of 10 bleeding sites based on the BI
  • Absence of advanced periodontitis based on a clinical examination at Baseline and discretion of the dental examiner

Exclusion criteria

  • History of significant adverse effects, including sensitivities or suspected allergies, following use of oral hygiene products such as toothpastes, mouth rinses and red food dye
  • Dental prophylaxis within four weeks prior to Screening/Baseline visit
  • History of medical conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
  • Antibiotic, anti-inflammatory or anticoagulant therapy during the study or within the one month prior to the Baseline exam. Intermittent use of certain anti-inflammatory medication is acceptable at the discretion of the Investigator
  • Use of chemotherapeutic anti-plaque/anti-gingivitis products such as triclosan, essential oils, cetylpyridinium chloride, stannous fluoride or chlorhexidine containing mouth rinses within the two weeks prior to Baseline

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

149 participants in 4 patient groups

Group 1: Listerine Cool Mint Mouth Rinse (Marketed product)
Experimental group
Description:
Participants will receive Alcohol-containing Essential Oil (AEO) containing mouth rinse (Listerine Cool Mint, marketed) orally for 12 weeks. Participant will brush their teeth and rinse once daily under supervision during the week (five days) for 30 seconds with 20 milliliter (mL) of mouth rinse and brush their teeth and rinse a second time each day during the week at home. During the weekends, participants will brush twice daily in their usual manner, following rinsing with their assigned mouth rinse, unsupervised at home.
Treatment:
Other: Alcohol-containing Essential Oil (AEO) Mouth Rinse (Listerine Cool Mint, marketed)
Other: Colgate Cavity Protection Toothpaste
Other: American Dental Association (ADA) Referenced Toothbrush
Group 2: Negative Control (5 Percent (%) Hydroalcohol Mouth Rinse)
Experimental group
Description:
Participants will receive negative control mouth rinse (5% Hydroalcohol mouth rinse) orally for 12 weeks. Participant will brush their teeth and rinse once daily under supervision during the week (five days) for 30 seconds with 20 milliliter (mL) of mouth rinse and brush their teeth and rinse a second time each day during the week at home. During the weekends, participants will brush twice daily in their usual manner, following rinsing with their assigned mouth rinse, unsupervised at home.
Treatment:
Other: Colgate Cavity Protection Toothpaste
Other: American Dental Association (ADA) Referenced Toothbrush
Other: 5% Hydroalcohol Mouth Rinse
Group 3: Flossing Performed by Dental Hygienist
Experimental group
Description:
Participants will brush their teeth and then undergo instructions on flossing technique using reach dental floss orally for 12 Weeks. Dental hygienist will floss participant's teeth at the site once daily during the week (five days). The second brushing will be done unsupervised at home. The remaining weekend days flossing and brushing will be done unsupervised at home.
Treatment:
Other: Colgate Cavity Protection Toothpaste
Other: REACH Dental Floss
Other: American Dental Association (ADA) Referenced Toothbrush
Group 4: Flossing under Supervision
Experimental group
Description:
Participants will brush their teeth and then undergo instructions on flossing technique using reach dental floss orally for 12 Weeks. Participants floss their teeth under supervision at the site once daily during the week (five days). The second brushing will be done unsupervised at home. The remaining weekend days flossing and brushing will be done unsupervised at home.
Treatment:
Other: Colgate Cavity Protection Toothpaste
Other: REACH Dental Floss
Other: American Dental Association (ADA) Referenced Toothbrush

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems